REVASCULARIZATION IGNORED? “With about 800,000 acute heart attacks occurring in the U.S. every year, and heart disease being the number one killer, you would think that a new clinical trial showing benefits from opening up all significantly blocked heart blood vessels in addition to the blocked artery responsible for the acute attack would merit big headlines. Think again. You would be wrong. Not only were there no big headlines, there was no coverage at all.”